NXTC: NextCure, Inc. Stock

by  •  • Comments Off on NXTC: NextCure, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 36.09
Enterprise Value ($M) 23.00
Book Value ($M) 114.42
Book Value / Share 4.09
Price / Book 0.32
NCAV ($M) 99.11
NCAV / Share 3.54
Price / NCAV 0.36

Profitability (mra)
Return on Invested Capital (ROIC) -0.52
Return on Assets (ROA) -0.37
Return on Equity (ROE) -0.41

Liquidity (mrq)
Quick Ratio 16.38
Current Ratio 16.38

Balance Sheet (mrq) ($M)
Current Assets 112.72
Assets 128.04
Liabilities 13.62
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -67.64
Net Income -62.72
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -52.97
Cash from Investing 39.27
Cash from Financing 0.15

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-01 13G Logos Global Management LP 7.20
03-08 13D/A Orbimed Advisors Llc 4.50 -53.23
01-19 13G/A Millennium Management Llc 4.10 -21.35

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 7,511 55,284 13.59
2024-04-25 14,874 156,328 9.51
2024-04-24 24,890 13,719 181.43
2024-04-23 6,925 8,685 79.74
2024-04-22 6,919 43,767 15.81

(click for more detail)

Similar Companies
NMRA – Neumora Therapeutics, Inc. NUVL – Nuvalent, Inc.
NVAX – Novavax, Inc. OGI – Organigram Holdings Inc.
OLMA – Olema Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io